1. Arechaga, G., Sánchez, B., Alba, F., de Dios Luna, J., Luttenauer, L., Martínez, J.M., et al. (1995) Subcellular distribution of soluble and membrane-bound Arg-beta-naphthylamide hydrolyzing activities in the developing and aged rat brain. Cell Mol Biol Res. 41, 369–375.
2. Checler, F. (1993) Methods in neurotransmitter and neuropeptide research. Parvez, S.H., Naoi, M., Nagatsu, T., Parvez, S. (Eds), Elsevier, Amsterdam.
3. Noble, F. and Roques, B.P. (2007) Protection of endogenous enkephalin catabolism as natural approach to novel analgesic and antidepressant drugs. Expert Opin Ther Targets. 11, 145–159.
4. Bodineau, L., Frugière, A., Marc, Y., Inguimbert, N., Fassot, C., Balavoine, F. et al. (2008) Orally active aminopeptidase A inhibitors reduce blood pressure: a new strategy for treating hypertension. Hypertension. 51, 1318–1325.
5. Stragier, B., De Bundel, D., Sarre, S., Smolders, I., Vauquelin, G., Dupont, A. et al. (2008) Involvement of insulin-regulated aminopeptidase in the effects of the renin-angiotensin fragment angiotensin IV: a review. Heart Fail Rev.
13, 321–337.